Anxiety Disorders, Breastfeeding, Neonatal Outcomes
Conditions
Brief summary
A randomized control trial was made to examine the effects of breastfeeding support given by the video-conferencing method in the early postpartum period on anxiety, breastfeeding self-efficiency, and newborn outcomes.
Interventions
No intervention
Sponsors
Study design
Eligibility
Inclusion criteria
Infants; * Born between 37 and 42 weeks * Without severe congenital anomalies Mothers; * A single live birth * Were 18 years of age or over * At least primary school graduate * Did not have a disease that prevents breastfeeding * Had internet access at home or on the phone * Could speak and understand the Turkish language.
Exclusion criteria
* Situations that cause separation of mother and baby * Hospitalization of the baby in intensive care * Inability to answer 3 calls in a video call * They were determined as those who could not be reached during the home visit for the first and second follow
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The mean postpartum maternal anxiety level (mean ± SD) | at 2 weeks and 4 weeks after delivery | The primary outcome of this study was the mean postpartum maternal anxiety level (mean ± SD) of the mothers at 2 weeks and 4 weeks after delivery. Maternal anxiety level was assessed using the Postpartum Specific Anxiety Scale. The scale comprises 51 items and 4 sub-dimensions. It means that those who score 73 and below on the scale have low postpartum anxiety levels, those who score between 74 and 100 have a medium level, and those who score 101 and above have a high level of anxiety. |
| The mean breastfeeding self-efficacy level | at 2 weeks and 4 weeks after delivery | The other main outcome of the study was the mean breastfeeding self-efficacy level (mean ± SD) measured with the Breastfeeding Self-Efficacy Scale Short Form. The scale is likert type and a total score between 14 and 70 is taken from the scale. The higher the score, the higher the breastfeeding self-efficacy. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Neonatal outcomes-Need for phototherapy | at 2 weeks and 4 weeks after delivery | The need for phototherapy was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery |
| Neonatal outcomes-Respiratory morbidity | at 2 weeks and 4 weeks after delivery | Respiratory morbidity was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery |
| Neonatal outcomes-Newborn weight (g) | at 2 weeks and 4 weeks after delivery | Newborn weight (g) was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery |
| Neonatal outcomes-Food intake other than breast milk | at 2 weeks and 4 weeks after delivery | Food intake other than breast milk was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery |
| Neonatal outcomes-Neonatal death | at 2 weeks and 4 weeks after delivery | Neonatal death was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery |
| Neonatal outcomes-illness requiring hospitalization | at 2 weeks and 4 weeks after delivery | Illness requiring hospitalization was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery |
| Neonatal outcomes-Hypoglycemia of the newborn | at 2 weeks and 4 weeks after delivery | Hypoglycemia of the newborn was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery. |
Countries
Turkey (Türkiye)